Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06406075
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-05-09
First Post:
2024-04-11
Brief Title:
Non-invasive Measurement of Glucose with Advanced Spectroscopy Techniques and Machine Learning Models
Sponsor:
Spiden AG
Organization:
Spiden AG
Study Overview
Official Title:
A Pilot Study to Assess the Ability of Advanced Spectroscopy Techniques and Machine Learning Models to Non-invasively Measure Glucose Robustly and Accurately
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Primary aim of this pilot study is to provide evidence for a non-invasive continuous and transcutaneous measurement method to determine blood glucose levels robustly and accurately
Detailed Description:
The study is divided into 3 sub-studies focusing on
Interchangeability of Lab demo 10
Evaluation of advanced spectroscopy methods and their miniaturisation potential
Robustness of machine learning model to changes over time
Interchangeability of Lab demo 10
Evaluation of advanced spectroscopy methods and their miniaturisation potential
Robustness of machine learning model to changes over time
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None